Reagent Test Strips for Blood, Urobilinogen, Bilirubin, Protein, Nitrite, Ketones, Ascorbic Acid, Glucose, pH, Specific Gravity and Leucocytes in Urine by the Dip and Read Technique.
Published May 22, 2024 · Recall initiated: April 4, 2024
Summary
FDA records medical device Class II recall Z-1834-2024, published May 22, 2024 and initiated April 4, 2024. Recalling firm: Macherey Nagel Gmbh & Co. Kg; Status: Ongoing; Reported quantity: 5,200 packages; Lot: Product #102-2285, UDI/DI: 00304040001479, LOT 65402. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The reason for the recall is one of the test pads, for the parameter leukocytes, was missing on some of the test strips. The issue was identified by a consumer by way of a Henry Schein Inc. (HSI) customer complaint. This problem can potentially result in the possibility that the parameter leucocytes (a non-specific marker for urinary track infections and an indicator for inflammatory renal processes) is interpreted instrumentally as a false negative. The following HSI item number and lot number were affected: Urispec® 11-Way, #102-2285, LOT 65402.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Macherey Nagel Gmbh & Co. Kg
- Distributor
- US Nationwide distribution in the states of CO, FL, IN, NV, TX.
- Lot
- Product #102-2285, UDI/DI: 00304040001479, LOT 65402.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- Germany
Related recalls
- FDAXelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: SunMay 29, 2024
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, ForMay 29, 2024
- FDAEchoTip® Ultra Endoscopic Ultrasound Access Needle, ECHO-19, G31520May 22, 2024
- FDACardinalHealth Curity Flexible Adhesive Bandage X-Large 2 x 3.75 in. (5.1 x 9.5 cm), Model 44102, Sterile,May 22, 2024
- FDAEchoTip® Ultra HD Endoscopic Ultrasound Access Needle, ECHO-HD-19-A, G52012May 22, 2024
- FDACARDIOHELP-i System. Blood oxygenation and carbon dioxide removal system.May 22, 2024
Questions about this recall
Was Reagent Test Strips for Blood, Urobilinogen, Bilirubin, Protein, Nitrite, Ketones, Ascorbic Acid, Glucose, pH, Specific Gravity and Leucocytes in Urine by the Dip and Read Technique. recalled?
Yes. FDA published recall Z-1834-2024 on May 22, 2024. Reported hazard: The reason for the recall is one of the test pads, for the parameter leukocytes, was missing on some of the test strips. The issue was identified by a consumer by way of a Henry Schein Inc. (HSI) customer complaint. This problem can potentially result in the possibility that the parameter leucocytes (a non-specific marker for urinary track infections and an indicator for inflammatory renal processes) is interpreted instrumentally as a false negative. The following HSI item number and lot number were affected: Urispec® 11-Way, #102-2285, LOT 65402.
What should I do if I have this product?
Voluntary: Firm initiated · Letter